The article content continued
What are you doing by stopping some high-profile vaccine trials this week?
“I would say that something similar is relatively common. When we look at trials that can involve as many as 50,000 people, I would not say that it is too unique that you will have the potential for a stopped trial, whereby because of some kind of complication or because of some kind of a disease that you need to make further examinations.
“Is the scientific rigor of any question considered, how urgent is it to try to get something out, and the speed with which we are going through this development process for some of the most important candidate vaccines? By ceasing your own lawsuit ̵
Is it probably an annual or one-time vaccine, or can there be multiple versions around the world?
Many of these questions depend on the type of vaccine that emerges and whether it is more of a universal approach versus something that is really just strict (COVID-19) … It also depends on the type of vaccine you develop … It may not be for all age groups and can only be for for example adults from 18 to 40 …
“While we have several (vaccine) candidates, not everyone will make it to the final approval in the end. So it is important to have a number of shots online for a number of reasons for many of these variables … We do not really know the trajectory of what COVID-19 will look like and what COVID-20 will look like … ”
Is it possible that treatment is the best solution, or does this pandemic end with a vaccine?
“I have no doubt that it will eventually end up with a vaccine. I think the important part to understand here is that the development of a vaccine is not a simple thing … One thing I can say is that watching the development process work this fast with this number ( vaccine) candidates are unseen. This is truly a unique time in history at the scientific level. ”